JENNIFER FACTEAU-RABIDEAU: Open Payments
NPI 1437406477 · PLATTSBURGH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,512 in 128 payments from 17 companies in 2025. Trend: 2023 $1,831 · 2024 $2,357 · 2025 $2,512
Food & beverage: $2,512
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 26 | $527 |
| Novo Nordisk Inc | 22 | $459 |
| ABBVIE INC. | 23 | $415 |
| GlaxoSmithKline, LLC. | 14 | $256 |
| PFIZER INC. | 13 | $211 |
| Lilly USA, LLC | 7 | $150 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $66 |
| Gilead Sciences, Inc. | 3 | $58 |
| Amgen Inc. | 3 | $56 |
Products named: QULIPTA, AIRSUPRA, TRELEGY ELLIPTA, Ozempic, Rybelsus, FARXIGA, NURTEC ODT, REXULTI.
Industry payments across NY — which companies pay providers there.
